This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
IL-2 immunotherapy for targeting regulatory T cells in autoimmunity
Genes & Immunity Open Access 23 September 2023
-
Early-onset autoimmunity associated with SOCS1 haploinsufficiency
Nature Communications Open Access 21 October 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Chen, X., Bäumel, M., Männel, D.N., Howard, O.M. & Oppenheim, J.J. J. Immunol. 179, 154–161 (2007).
Chen, X. et al. J. Immunol. 180, 6467–6471 (2008).
Grinberg-Bleyer, Y. et al. J. Clin. Invest. 120, 4558–4568 (2010).
Valencia, X. et al. Blood 108, 253–261 (2006).
Nagar, M. et al. J. Immunol. 184, 3570–3581 (2010).
Zanin-Zhorov, A. et al. Science 328, 372–376 (2010).
Nie, H. et al. Nat. Med. 19, 322–328 (2013).
Kim, E.Y., Priatel, J.J., Teh, S.J. & Teh, H.S. J. Immunol. 176, 1026–1035 (2006).
Tartaglia, L.A. et al. J. Immunol. 151, 4637–4641 (1993).
Chen, X. et al. J. Immunol. 185, 174–182 (2010).
Chen, X. et al. Eur. J. Immunol. 40, 1099–1106 (2010).
Ehrenstein, M.R. et al. J. Exp. Med. 200, 277–285 (2004).
Nadkarni, S., Mauri, C. & Ehrenstein, M.R. J. Exp. Med. 204, 33–39 (2007).
Acknowledgements
We thank G. Marodon for helpful discussion, M. Cherai for technical support and Y. Lombardi for statistical analyses. This work was supported by the Fondation Bettencourt Schueller and by the Association de la Recherche sur la Sclérose en Plaques.
Author information
Authors and Affiliations
Contributions
B.Z., X.C., J.J.O., M.M. and B.L.S. designed and discussed the initial project; B.Z., X.C., A.B., S.G., D.C., M.M. and B.L.S. performed experiments and analyzed data; G.G. gave conceptual advice; B.Z. and B.L.S. wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Figures and Tables
Supplementary Figures 1–8, Table 1 (PDF 917 kb)
Rights and permissions
About this article
Cite this article
Zaragoza, B., Chen, X., Oppenheim, J. et al. Suppressive activity of human regulatory T cells is maintained in the presence of TNF. Nat Med 22, 16–17 (2016). https://doi.org/10.1038/nm.4019
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4019
This article is cited by
-
IL-2 immunotherapy for targeting regulatory T cells in autoimmunity
Genes & Immunity (2023)
-
TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4+Foxp3+ regulatory T cells
Cellular Oncology (2023)
-
TNFR2 antagonist and agonist: a potential therapeutics in cancer immunotherapy
Medical Oncology (2022)
-
TNF in the era of immune checkpoint inhibitors: friend or foe?
Nature Reviews Rheumatology (2021)
-
Interleukin-2 and regulatory T cells in rheumatic diseases
Nature Reviews Rheumatology (2021)